Pyxis Oncology Inc (PYXS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.52
• Market Cap: $92.15M
• EPS: $-1.58
• 52-Week High: $5.55
• 52-Week Low: $0.83

Market Sentiment

Pyxis Oncology Inc currently has a Bullish sentiment score of 0.36.

About Pyxis Oncology Inc

Pyxis Oncology, Inc. is a preclinical biotechnology firm based in Cambridge, Massachusetts, focused on advancing innovative therapies for cancer treatment through the development of antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs). With a commitment to harnessing the power of targeted therapies, Pyxis aims to enhance the efficacy and safety profiles of oncology treatments, addressing unmet medical needs in the oncology landscape. The company's cutting-edge research and strateg...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Pyxis Oncology Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PYXS pay dividends?

Pyxis Oncology Inc (PYXS) does not currently pay a regular dividend.

What is PYXS's market cap?

Pyxis Oncology Inc (PYXS) has a market capitalization of $92.15M with a current stock price of $1.52.